| |
| |
Contributors | |
| |
| |
Foreword | |
| |
| |
| |
Contemporary Context | |
| |
| |
| |
Definition, Recognition and Assessment | |
| |
| |
| |
Introduction | |
| |
| |
Definition and terminology | |
| |
| |
General considerations in the recognition and assessment of dual diagnosis | |
| |
| |
How significant is the problem of dual diagnosis? | |
| |
| |
Recognition and assessment | |
| |
| |
Hypotheses | |
| |
| |
Conclusion | |
| |
| |
| |
Explanatory Models for Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
Is substance misuse more prevalent among people with psychotic illnesses than in the general population? | |
| |
| |
Which problem generally develops first in dual diagnosis? | |
| |
| |
Does dual diagnosis have a neurobiological basis? | |
| |
| |
Is dual diagnosis mediated by personality disorder? | |
| |
| |
Do people with schizophrenia use substances as a form of self-medication? | |
| |
| |
Have changes in the care and social circumstances of people with schizophrenia, particularly deinstitutionalisation, led to a rise in substance misuse in this population? | |
| |
| |
Do the social situations and social difficulties of people with schizophrenia lead to substance use? | |
| |
| |
Do people with schizophrenia tend to begin using drugs and alcohol within mental health service settings or in the company of other users of such services? | |
| |
| |
Conclusion | |
| |
| |
| |
Consumer Perspectives | |
| |
| |
| |
Introduction | |
| |
| |
Human experience and medicine | |
| |
| |
Diagnosis, treatment and human rights | |
| |
| |
Two worlds | |
| |
| |
Significant contrasts | |
| |
| |
Diagnosis | |
| |
| |
Treatment | |
| |
| |
Dual diagnosis and policy | |
| |
| |
Conclusion | |
| |
| |
| |
Common Presentations and Special Populations | |
| |
| |
| |
Risk Assessment and Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
Clinical risk assessment | |
| |
| |
Principles of risk assessment and management | |
| |
| |
The process of risk assessment and management | |
| |
| |
Conclusion | |
| |
| |
| |
Reducing Drug-Related Harm Among Mentally Ill People | |
| |
| |
| |
Introduction | |
| |
| |
Interventions and approaches | |
| |
| |
Harm reduction | |
| |
| |
Using harm reduction approaches with mentally ill individuals | |
| |
| |
Dual diagnosis and harm reduction: the future? | |
| |
| |
Conclusion | |
| |
| |
| |
Motivational Interviewing | |
| |
| |
| |
Introduction | |
| |
| |
What is MI? | |
| |
| |
Conclusion | |
| |
| |
| |
Psychological Interventions | |
| |
| |
| |
Introduction | |
| |
| |
The nature and type of psychological interventions | |
| |
| |
The evidence for psychological interventions in dual diagnosis | |
| |
| |
Individual therapies | |
| |
| |
Group therapies | |
| |
| |
Cognitive behaviour therapy and relapse prevention | |
| |
| |
Family interventions | |
| |
| |
Contingency management | |
| |
| |
Conclusion | |
| |
| |
| |
Alcohol and Mood Disorders | |
| |
| |
| |
Introduction | |
| |
| |
Harm, alcohol and mental illness | |
| |
| |
Presentation: alcohol and mental illness | |
| |
| |
Medication and dual diagnosis | |
| |
| |
Conclusion | |
| |
| |
| |
Polysubstance Use and Personality Disorder | |
| |
| |
| |
Introduction | |
| |
| |
Prevalence | |
| |
| |
Service delivery | |
| |
| |
What is personality disorder? | |
| |
| |
Treatment and intervention approaches | |
| |
| |
Assessment | |
| |
| |
Stages of change | |
| |
| |
Therapeutic principles | |
| |
| |
Conclusion | |
| |
| |
| |
Older People and Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
An increasing population | |
| |
| |
Policy framework | |
| |
| |
Media representation of information on alcohol | |
| |
| |
Perception of old age | |
| |
| |
Alcohol use in older people | |
| |
| |
Complications of excessive alcohol use | |
| |
| |
Assessment and screening | |
| |
| |
Under-reporting | |
| |
| |
Over-the-counter medication (OTC) | |
| |
| |
Prescribed medication | |
| |
| |
Conclusion | |
| |
| |
| |
Stimulant Use and Psychosis | |
| |
| |
| |
Introduction | |
| |
| |
Stimulant use in the United Kingdom | |
| |
| |
Stimulants and drug-induced psychosis | |
| |
| |
Stimulants and mental illness | |
| |
| |
Stimulants and their use by people with existing psychotic illnesses | |
| |
| |
Implications for practice | |
| |
| |
Conclusion | |
| |
| |
| |
Women and Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
Gender differences in dual diagnosis | |
| |
| |
The impact of dual diagnosis on families | |
| |
| |
Dual diagnosis and domestic violence | |
| |
| |
Dual diagnosis within the female prison service | |
| |
| |
A case for gender-specific services | |
| |
| |
Conclusion | |
| |
| |
| |
Drug-Induced Psychosis | |
| |
| |
| |
Introduction | |
| |
| |
Dual diagnosis: a common problem | |
| |
| |
The relationship between substance use and psychosis: aetiology | |
| |
| |
A model of relationships between psychotic illness and drug and alcohol use | |
| |
| |
Conclusion | |
| |
| |
| |
Cannabis Use and Psychosis | |
| |
| |
| |
Introduction | |
| |
| |
What is cannabis? | |
| |
| |
How is it used? | |
| |
| |
Legal issues | |
| |
| |
How it affects the user | |
| |
| |
Psychological effects | |
| |
| |
Physical effects | |
| |
| |
Safety issues | |
| |
| |
The links between cannabis and psychosis | |
| |
| |
Interventions for cannabis and psychosis | |
| |
| |
Conclusion | |
| |
| |
| |
Methamphetamine and Mental Health | |
| |
| |
| |
Introduction | |
| |
| |
Initiation and continuation of methamphetamine use: missed opportunities | |
| |
| |
Methamphetamine and mental health: intoxication, withdrawal and psychiatric illness | |
| |
| |
Methamphetamine addiction: treatment and outcomes | |
| |
| |
Conclusion | |
| |
| |
Acknowledgements | |
| |
| |
| |
Public Health and Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
Epidemiology | |
| |
| |
Causal relationship | |
| |
| |
Treatment for BBV | |
| |
| |
Other co-infections | |
| |
| |
Conclusion | |
| |
| |
| |
Comorbidity or Complexity: A Primary Care Perspective on Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
Policy framework | |
| |
| |
Epidemiology | |
| |
| |
Key features of general practice care | |
| |
| |
Physical health care | |
| |
| |
Mental health and substance misuse care | |
| |
| |
Limitations and potential in primary care | |
| |
| |
Conclusion | |
| |
| |
| |
International Perspectives, Policy and Development | |
| |
| |
| |
Dual Diagnosis North America | |
| |
| |
| |
Introduction | |
| |
| |
Prevalence | |
| |
| |
Historical context | |
| |
| |
Socio-cultural and public policy considerations | |
| |
| |
Approaches to treatment | |
| |
| |
Research | |
| |
| |
Issues and challenges | |
| |
| |
Conclusion | |
| |
| |
| |
Dual Diagnosis Australasia | |
| |
| |
| |
Introduction | |
| |
| |
Drivers for system change | |
| |
| |
Consumer and carer demand | |
| |
| |
Prevalence | |
| |
| |
Harms and unwanted outcomes strongly associated with dual diagnosis | |
| |
| |
Opportunity to provide more effective treatment of target | |
| |
| |
disorders via improved recognition and more effective responses to co-occurring disorders | |
| |
| |
Barriers to better outcomes for persons with dual diagnosis | |
| |
| |
Indigenous Australians | |
| |
| |
Rural and remote regions of Australia | |
| |
| |
Australi's responses to dual diagnosis | |
| |
| |
Structure of the Australian health care system | |
| |
| |
National level responses to dual diagnosis | |
| |
| |
The National Comorbidity Initiative | |
| |
| |
Improved Services for People with Drug and Alcohol Problems and Mental Illness Measure | |
| |
| |
Can Do | |
| |
| |
Managing Mental Health and Substance Use in General | |
| |
| |
Practice | |
| |
| |
Headspace | |
| |
| |
State level responses to dual diagnosis | |
| |
| |
Conclusion | |
| |
| |
| |
Dual Diagnosis Europe | |
| |
| |
| |
Introduction | |
| |
| |
The historical and social context | |
| |
| |
Elements of dual diagnosis in the region | |
| |
| |
Alcohol | |
| |
| |
Other psychoactive substances | |
| |
| |
Care and treatment responses | |
| |
| |
Problems and solutions | |
| |
| |
Conclusion | |
| |
| |
| |
Commissioning Services for Users with Dual Diagnosis | |
| |
| |
| |
Introduction | |
| |
| |
Background | |
| |
| |
The history of commissioning | |
| |
| |
Implications for commissioning dual diagnosis services | |
| |
| |
Conclusion | |
| |
| |
| |
Practice, Research and Education Development | |
| |
| |
| |
Introduction | |
| |
| |
Research | |
| |
| |
Education development | |
| |
| |
Practice | |
| |
| |
Conclusion | |
| |
| |
Index | |